Ongoing vaccine and monoclonal antibody HIV prevention efficacy trials and considerations for sequel efficacy trial designs
PB Gilbert - Statistical communications in infectious diseases, 2019 - degruyter.com
Four randomized placebo-controlled efficacy trials of a candidate vaccine or passively
infused monoclonal antibody for prevention of HIV-1 infection are underway (HVTN 702 in …
infused monoclonal antibody for prevention of HIV-1 infection are underway (HVTN 702 in …